Comment
Author: Admin | 2025-04-28
Pediatric, NeoProfen, Nuprin, PediaCare Children's IB Ibuprofen Pain Reliever/Fever Reducer, PediaCare Infants' IB Ibuprofen Pain Reliever/Fever Reducer, Proprinal View more N/A Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. 18 hours 4 hours 3.5 hours CSA Schedule ** View glossary of terms Is not subject to the Controlled Substances Act. Is not subject to the Controlled Substances Act. Is not subject to the Controlled Substances Act. Pregnancy Category See the full pregnancy warnings document. Prior To 30 Weeks Gestation Starting At 30 Weeks Gestation See the full pregnancy warnings document. See the full pregnancy warnings document. Drug Interactions A total of 435 drugs are known to interact with Naproxen: 98 major drug interactions (431 brand and generic names) 319 moderate drug interactions (1286 brand and generic names) 18 minor drug interactions (130 brand and generic names) A total of 398 drugs are known to interact with Ibuprofen: 98 major drug interactions (434 brand and generic names) 285 moderate drug interactions (1110 brand and generic names) 15 minor drug interactions (80 brand and generic names) A total of 394 drugs are known to interact with Mefenamic acid: 96 major drug interactions (413 brand and generic names) 283 moderate drug interactions (1164 brand and generic names) 15 minor drug interactions (85 brand and generic names) Alcohol/Food/Lifestyle Interactions Ask your doctor before using naproxen together with alcohol. Do not drink alcohol while taking... View more Ask your doctor before using ibuprofen together with alcohol. Do not drink alcohol while taking... View more Ask your doctor before using mefenamic acid together with alcohol. Do not drink alcohol while... View more Disease Interactions Asthma Fluid retention GI toxicity Rash Renal toxicities Thrombosis Sodium Anemia Hepatotoxicity Hyperkalemia Platelet aggregation inhibition Asthma Fluid retention GI toxicity Rash Renal toxicities Thrombosis PKU Anemia Hepatotoxicity Hyperkalemia Platelet aggregation inhibition Asthma Fluid retention GI toxicity Rash Renal toxicities Thrombosis Anemia Hepatotoxicity Hyperkalemia Platelet aggregation inhibition First Approval Date March 11, 1976 September 19, 1974 March 28, 1967 WADA Class View World Anti-Doping Agency
Add Comment